CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $18.11M, above the global median of $16.24M
- FinancialsAltman Z-Score 3.49: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
6.03%Above 5Y avg (2.85%)
Annual Rate
HKD 0.14Paid semi-annual
Payout Ratio
29.9%Sustainable
Last Ex-Dividend
Aug 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.39BHKD304.33M · vs all stocks (USD)
Trailing P/E
5.00xRevenue (TTM)
1.72BHKD219.53M · vs all stocks (USD)
Profit Margin
15.41%Beta
0.0170xvs all stocks
52-Week Change
-59.44%vs all stocks
Forward Annual Dividend Yield
6.03%vs all stocks
Market Capitalization
2.39BHKD304.33M · vs all stocks (USD)
Enterprise Value
873.72MHKD111.39M · vs all stocks (USD)
Trailing P/E
5.00xForward P/E
8.70xPEG Ratio
-0.0500xPrice to Sales (TTM)
0.7720xPrice to Book (MRQ)
0.5227xEnterprise to Revenue
0.5070xEnterprise to EBITDA
2.20xProfit Margin
15.41%Operating Margin
17.61%Return on Assets (TTM)
6.27%Return on Equity (TTM)
11.01%Revenue (TTM)
1.72BHKD219.53M · vs all stocks (USD)
Revenue per Share (TTM)
3.04HKDUpdated Aug 19, 2026Quarterly Revenue Growth
-10.50%Gross Profit (TTM)
1.50BHKD190.67M · vs all stocks (USD)
EBITDA (TTM)
492.99MHKD62.85M · vs all stocks (USD)
Net Income (TTM)
265.41MHKD33.84M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-32.20%Operating Cash Flow (TTM)
282.52MHKD36.02M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
142.05MHKD18.11M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1400HKDUpdated Aug 19, 2026Forward Annual Dividend Yield
6.03%vs all stocks
Trailing Annual Dividend Rate
0.1400HKDUpdated Aug 19, 2026Trailing Annual Dividend Yield
6.03%vs all stocks
5-Year Average Dividend Yield
2.85%vs all stocks
Payout Ratio
29.91%Revenue
1.81BHKDFY2025 · Dec 31, 2025Cost of Goods Sold
195.92MHKDFY2025 · Dec 31, 2025Gross Profit
1.62BHKDFY2025 · Dec 31, 2025Operating Income
413.45MHKD52.71M · vs all stocks (USD)
Pre-tax Income
414.66MHKDFY2025 · Dec 31, 2025Income Tax Expense
96.57MHKDFY2025 · Dec 31, 2025Net Income
318.09MHKDFY2025 · Dec 31, 2025EBIT
422.48MHKDFY2025 · Dec 31, 2025EBITDA (Income Statement)
492.99MHKDFY2025 · Dec 31, 2025Selling, General & Administrative
1.21BHKDFY2025 · Dec 31, 2025Non-operating Interest Income
11.83MHKDFY2025 · Dec 31, 2025Non-operating Interest Expense
7.82MHKDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00HKDFY2025 · Dec 31, 2025Operating Cash Flow
302.98MHKDFY2025 · Dec 31, 2025Free Cash Flow
195.55MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
782.73MHKDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
414.66MHKDFY2025 · Dec 31, 2025Other Non-cash Items
-6.51MHKDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-86.82MHKDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.35MHKDFY2025 · Dec 31, 2025Capital Expenditures
-107.43MHKDFY2025 · Dec 31, 2025Net Intangibles (CF)
-67.10MHKDFY2025 · Dec 31, 2025Net Acquisitions
-1.05MHKDFY2025 · Dec 31, 2025Sale of Investments
0.00HKDFY2025 · Dec 31, 2025Net Investing Cash Flow
-108.49MHKDFY2025 · Dec 31, 2025Long-term Debt Issuance
233.87MHKDFY2025 · Dec 31, 2025Long-term Debt Payments
-82.44MHKDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
0.00HKDFY2025 · Dec 31, 2025Common Stock Repurchase
-325.27KHKDFY2025 · Dec 31, 2025Common Dividends Paid
-73.71MHKDFY2025 · Dec 31, 2025Net Financing Cash Flow
77.40MHKDFY2025 · Dec 31, 2025Shares Outstanding
567.01MSharesUpdated Aug 19, 2026Float Shares
260.37MSharesUpdated Aug 19, 2026% Held by Insiders
54.25%vs all stocks
% Held by Institutions
1.16%vs all stocks
Total Cash (MRQ)
807.73MHKD102.98M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.43HKDUpdated Aug 19, 2026Total Debt (MRQ)
348.99MHKD44.49M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1369xCurrent Ratio (MRQ)
2.15xBook Value per Share (MRQ)
4.50HKDUpdated Aug 19, 2026Total Assets
3.49BHKD445.04M · vs all stocks (USD)
Total Current Assets
1.62BHKDFY2025 · Dec 31, 2025Total Liabilities
1.08BHKDFY2025 · Dec 31, 2025Total Non-current Assets
1.87BHKDFY2025 · Dec 31, 2025Total Non-current Liabilities
310.77MHKDFY2025 · Dec 31, 2025Total Current Liabilities
766.91MHKDFY2025 · Dec 31, 2025Cash
572.76MHKDFY2025 · Dec 31, 2025Cash Equivalents
209.97MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents
782.73MHKDFY2025 · Dec 31, 2025Other Short-term Investments
1.41MHKDFY2025 · Dec 31, 2025Accounts Receivable
656.55MHKDFY2025 · Dec 31, 2025Inventory
79.40MHKDFY2025 · Dec 31, 2025Accounts Payable
11.56MHKDFY2025 · Dec 31, 2025Short-term Debt
69.10MHKDFY2025 · Dec 31, 2025Long-term Debt
277.80MHKDFY2025 · Dec 31, 2025Common Stock (Book)
56.70MHKDFY2025 · Dec 31, 2025Retained Earnings
2.36BHKDFY2025 · Dec 31, 2025Total Shareholders' Equity
2.41BHKD307.64M · vs all stocks (USD)
52-Week Low
2.30HKDUpdated Aug 19, 202652-Week High
5.86HKDUpdated Aug 19, 202652-Week Change
-59.44%vs all stocks
Beta
0.0170xvs all stocks
50-Day MA
2.63HKDUpdated Aug 19, 2026200-Day MA
3.53HKDUpdated Aug 19, 2026Avg 10-Day Volume
378.90KSharesUpdated Aug 19, 2026Avg 30-Day Volume
395.23KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.4700HKDUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.49: safe zoneNotable
Altman Z-Score: 3.49
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $18.11M, above the global median of $16.24MNotable
Levered free cash flow (USD): 18,110,552.173Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Foghorn Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hikal Ltd.
Tier 1ProductionApproval-Gated PipelineRule
JBM
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tanvex Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
908 Devices Inc.
Tier 1ProductionApproval-Gated PipelineRule
Immuneering Corporation
Tier 1ProductionApproval-Gated PipelineRule
Il Dong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
AP Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Anhui Huangshan Capsule Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Neumora Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities